|

NNC0363-1063 Clinical Trials

2 actively recruiting trials

Pipeline

Phase 1: 2

Top Sponsors

  • Novo Nordisk A/S2

Indications

  • Diabetes Mellitus, Type 12
  • Diabetes2

Other2 trials

A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes
Phase 1
A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.